Pharmaceuticals

United States Anti-Obesity Drugs Industry 2016 Deep Market Research Report

  • QYR375615
  • 130 Pages
  • January 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
The United States Anti-Obesity Drugs Industry 2016 Deep Market Research Report is a professional and in-depth study on the current state of the Anti-Obesity Drugs industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Anti-Obesity Drugs market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Anti-Obesity Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 149 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents

1 Industry Overview

1.1 Definition and Specifications of Anti-Obesity Drugs

1.2 Classification of Anti-Obesity Drugs

1.3 Applications of Anti-Obesity Drugs

1.4 Industry Chain Structure of Anti-Obesity Drugs

1.5 Industry Overview of Anti-Obesity Drugs

1.6 Industry Policy Analysis of Anti-Obesity Drugs

1.7 Industry News Analysis of Anti-Obesity Drugs

2 Manufacturing Cost Structure Analysis of Anti-Obesity Drugs

2.1 Bill of Materials (BOM) of Anti-Obesity Drugs

2.2 BOM Price Analysis of Anti-Obesity Drugs

2.3 Labor Cost Analysis of Anti-Obesity Drugs

2.4 Depreciation Cost Analysis of Anti-Obesity Drugs

2.5 Manufacturing Cost Structure Analysis of Anti-Obesity Drugs

2.6 Manufacturing Process Analysis of Anti-Obesity Drugs

2.7 United States Price, Cost and Gross of Anti-Obesity Drugs 2011-2016

3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015

3.2 Manufacturing Plants Distribution of United States Key Anti-Obesity Drugs Manufacturers in 2015

3.3 R&D Status and Technology Source of United States Anti-Obesity Drugs Key Manufacturers in 2015

3.4 Raw Materials Sources Analysis of United States Anti-Obesity Drugs Key Manufacturers in 2015

4 Production Analysis of Anti-Obesity Drugs by Regions, Type, and Applications

4.1 United States Production of Anti-Obesity Drugs by Regions 2011-2016

4.2 United States Production of Anti-Obesity Drugs by Type 2011-2016

4.3 United States Sales of Anti-Obesity Drugs by Applications 2011-2016

4.4 Price Analysis of United States Anti-Obesity Drugs Key Manufacturers in 2015

4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Anti-Obesity Drugs 2011-2016

5 Consumption Volume and Consumption Value Analysis of Anti-Obesity Drugs by Regions

5.1 United States Consumption Volume of Anti-Obesity Drugs by Regions 2011-2016

5.2 United States Consumption Value of Anti-Obesity Drugs by Regions 2011-2016

5.3 United States Consumption Price Analysis of Anti-Obesity Drugs by Regions 2011-2016

6 Analysis of Anti-Obesity Drugs Production, Supply, Sales and Market Status 2011-2016

6.1 Capacity, Production, Sales, and Revenue of Anti-Obesity Drugs 2011-2016

6.2 Production Market Share and Sales Market Share Analysis of Anti-Obesity Drugs 2014-2015

6.3 Sales Overview of Anti-Obesity Drugs 2011-2016

6.4 Supply, Consumption and Gap of Anti-Obesity Drugs 2011-2016

6.5 Import, Export and Consumption of Anti-Obesity Drugs 2011-2016

6.6 Cost, Price, Revenue and Gross Margin of Anti-Obesity Drugs 2011-2016

7 Analysis of Anti-Obesity Drugs Industry Key Manufacturers

7.1 Pfizer

7.1.1 Company Profile

7.1.2 Product Picture and Specification

7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.1.4 Pfizer SWOT Analysis

7.2 Merck

7.2.1 Company Profile

7.2.2 Product Picture and Specification

7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.2.4 Merck SWOT Analysis

7.3 F. Hoffmann-La Roche

7.3.1 Company Profile

7.3.2 Product Picture and Specification

7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.3.4 F. Hoffmann-La Roche SWOT Analysis

7.4 GlaxoSmithKline

7.4.1 Company Profile

7.4.2 Product Picture and Specification

7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.4.4 GlaxoSmithKline SWOT Analysis

7.5 AstraZeneca

7.5.1 Company Profile

7.5.2 Product Picture and Specification

7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.5.4 AstraZeneca SWOT Analysis

7.6 Boehringer Ingelheim

7.6.1 Company Profile

7.6.2 Product Picture and Specification

7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.6.4 Boehringer Ingelheim SWOT Analysis

7.7 Novo Nordisk

7.7.1 Company Profile

7.7.2 Product Picture and Specification

7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.7.4 Novo Nordisk SWOT Analysis

7.8 Eisai

7.8.1 Company Profile

7.8.2 Product Picture and Specification

7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.8.4 Eisai SWOT Analysis

7.9 Norgine

7.9.1 Company Profile

7.9.2 Product Picture and Specification

7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.9.4 Norgine SWOT Analysis

7.10 Arena Pharmaceuticals

7.10.1 Company Profile

7.10.2 Product Picture and Specification

7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.10.4 Arena Pharmaceuticals SWOT Analysis

7.11 Orexigen Therapeutics

7.11.1 Company Profile

7.11.2 Product Picture and Specification

7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.11.4 Orexigen Therapeutics SWOT Analysis

7.12 Vivus

7.12.1 Company Profile

7.12.2 Product Picture and Specification

7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.12.4 Vivus SWOT Analysis

7.13 Alizyme

7.13.1 Company Profile

7.13.2 Product Picture and Specification

7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.13.4 Alizyme SWOT Analysis

7.14 Rhythm Pharmaceuticals

7.14.1 Company Profile

7.14.2 Product Picture and Specification

7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.14.4 Rhythm Pharmaceuticals SWOT Analysis

7.15 Shionogi

7.15.1 Company Profile

7.15.2 Product Picture and Specification

7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.15.4 Shionogi SWOT Analysis

7.16 Zafgan

7.16.1 Company Profile

7.16.2 Product Picture and Specification

7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.16.4 Zafgan SWOT Analysis

8 Price and Gross Margin Analysis

8.1 Analysis of Price

8.2 Gross Margin Analysis

8.3 Price Comparison by Regions

8.4 Price Analysis of Different Anti-Obesity Drugs Product Types

8.5 Market Share Analysis of Different Anti-Obesity Drugs Price Levels

8.6 Gross Margin Analysis of Different Anti-Obesity Drugs Applications

9 Marketing Trader or Distributor Analysis of Anti-Obesity Drugs

9.1 Marketing Channels Status of Anti-Obesity Drugs

9.2 Traders or Distributors of Anti-Obesity Drugs with Contact Information

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Anti-Obesity Drugs

9.4 United States Import, Export and Trade Analysis of Anti-Obesity Drugs

10 Development Trend of Anti-Obesity Drugs Industry 2016-2021

10.1 Capacity and Production Overview of Anti-Obesity Drugs 2016-2021

10.2 Production Market Share by Product Types of Anti-Obesity Drugs 2016-2021

10.3 Sales and Sales Revenue Overview of Anti-Obesity Drugs 2016-2021

10.4 United States Sales of Anti-Obesity Drugs by Applications 2016-2021

10.5 Import, Export and Consumption of Anti-Obesity Drugs 2016-2021

10.6 Cost, Price, Revenue and Gross Margin of Anti-Obesity Drugs 2016-2021

11 Industry Chain Suppliers of Anti-Obesity Drugs with Contact Information

11.1 Major Raw Materials Suppliers of Anti-Obesity Drugs with Contact Information

11.2 Manufacturing Equipment Suppliers of Anti-Obesity Drugs with Contact Information

11.3 Major Players of Anti-Obesity Drugs with Contact Information

11.4 Key Consumers of Anti-Obesity Drugs with Contact Information

11.5 Supply Chain Relationship Analysis of Anti-Obesity Drugs

12 New Project Investment Feasibility Analysis of Anti-Obesity Drugs

12.1 New Project SWOT Analysis of Anti-Obesity Drugs

12.2 New Project Investment Feasibility Analysis of Anti-Obesity Drugs

13 Conclusion of the United States Anti-Obesity Drugs Industry 2016 Deep Market Research Report

List of Tables and Figures

Figure Picture of Anti-Obesity Drugs

Table Product Specifications of Anti-Obesity Drugs

Table Classification of Anti-Obesity Drugs

Figure United States Sales Market Share of Anti-Obesity Drugs by Product Types in 2015

Table Applications of Anti-Obesity Drugs

Figure United States Sales Market Share of Anti-Obesity Drugs by Applications in 2015

Figure Industry Chain Structure of Anti-Obesity Drugs

Table United States Industry Overview of Anti-Obesity Drugs

Table Industry Policy of Anti-Obesity Drugs

Table Industry News List of Anti-Obesity Drugs

Table Bill of Materials (BOM) of Anti-Obesity Drugs

Table Bill of Materials (BOM) Price of Anti-Obesity Drugs

Table Labor Cost of Anti-Obesity Drugs

Table Depreciation Cost of Anti-Obesity Drugs

Table Manufacturing Cost Structure Analysis of Anti-Obesity Drugs in 2015

Figure Manufacturing Process Analysis of Anti-Obesity Drugs

Table United States Price Analysis of Anti-Obesity Drugs 2011-2016 (USD/Dose)

Table United States Cost Analysis of Anti-Obesity Drugs 2011-2016 (USD/Dose)

Table United States Gross Analysis of Anti-Obesity Drugs 2011-2016

Table Capacity (K Doses) and Commercial Production Date of United States Anti-Obesity Drugs Key Manufacturers in 2015

Table Manufacturing Plants Distribution of United States Key Anti-Obesity Drugs Manufacturers in 2015

Table R&D Status and Technology Source of United States Anti-Obesity Drugs Key Manufacturers in 2015

Table Raw Materials Sources Analysis of United States and United States Anti-Obesity Drugs Key Manufacturers in 2015

Table United States Production of Anti-Obesity Drugs by Regions 2011-2016 (K Doses)

Table United States Production Market Share of Anti-Obesity Drugs by Regions 2011-2016

Figure United States Production Market Share of Anti-Obesity Drugs by Regions in 2014

Figure United States Production Market Share of Anti-Obesity Drugs by Regions in 2015

Table United States Production of Anti-Obesity Drugs by Types in 2011-2016 (K Doses)

Table United States Production Market Share of Anti-Obesity Drugs by Type in 2011-2016

Figure United States Production Market Share of Anti-Obesity Drugs by Type in 2014

Figure United States Production Market Share of Anti-Obesity Drugs by Type in 2015

Table United States Sales of Anti-Obesity Drugs by Applications 2011-2016 (K Doses)

Table United States Production Market Share of Anti-Obesity Drugs by Applications 2011-2016

Figure United States Production Market Share of Anti-Obesity Drugs by Applications in 2014

Figure United States Production Market Share of Anti-Obesity Drugs by Applications in 2015

Table Price Comparison of United States Anti-Obesity Drugs Key Manufacturers in 2015 (USD/Dose)

Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Anti-Obesity Drugs 2011-2016

Table United States Consumption Volume of Anti-Obesity Drugs by Regions 2011-2016 (K Doses)

Table United States Consumption Volume Market Share of Anti-Obesity Drugs by Regions 2011-2016

Figure United States Consumption Volume Market Share of Anti-Obesity Drugs by Regions in 2014

Figure United States Consumption Volume Market Share of Anti-Obesity Drugs by Regions in 2015

Table United States Consumption Value of Anti-Obesity Drugs by Regions 2011-2016 (M USD)

Table United States Consumption Value Market Share of Anti-Obesity Drugs by Regions 2011-2016

Figure United States Consumption Value Market Share of Anti-Obesity Drugs by Regions in 2014

Figure United States Consumption Value Market Share of Anti-Obesity Drugs by Regions in 2015

Table Consumption Price of Anti-Obesity Drugs by Regions 2011-2016 (USD/Dose)

Table United States and Major Manufacturers Capacity of Anti-Obesity Drugs 2011-2016 (K Doses)

Table United States Capacity Market Share of Major Anti-Obesity Drugs Manufacturers 2011-2016

Table United States and Major Manufacturers Production of Anti-Obesity Drugs 2011-2016 (K Doses)

Table United States Production Market Share of Major Anti-Obesity Drugs Manufacturers 2011-2016

Table United States and Major Manufacturers Sales of Anti-Obesity Drugs 2011-2016 (K Doses)

Table United States Sales Market Share of Major Anti-Obesity Drugs Manufacturers 2011-2016

Table United States and Major Manufacturers Sales Revenue of Anti-Obesity Drugs 2011-2016 (M USD)

Table United States Sales Revenue Market Share of Major Anti-Obesity Drugs Manufacturers 2011-2016

Figure United States Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drugs 2011-2016

Figure United States Capacity Utilization Rate of Anti-Obesity Drugs 2011-2016

Figure United States Sales Revenue (M USD) and Growth Rate of Anti-Obesity Drugs 2011-2016

Figure United States Production Market Share of Major Anti-Obesity Drugs Manufacturers in 2014

Figure United States Production Market Share of Major Anti-Obesity Drugs Manufacturers in 2015

Figure United States Sales Market Share of Major Anti-Obesity Drugs Manufacturers in 2014

Figure United States Sales Market Share of Major Anti-Obesity Drugs Manufacturers in 2015

Figure United States Sales (K Doses) and Growth Rate of Anti-Obesity Drugs 2011-2016

Table United States Supply, Consumption and Gap of Anti-Obesity Drugs 2011-2016 (K Doses)

Table United States Import, Export and Consumption of Anti-Obesity Drugs 2011-2016 (K Doses)

Table Price of United States Anti-Obesity Drugs Major Manufacturers 2011-2016 (USD/Dose)

Table Gross Margin of United States Anti-Obesity Drugs Major Manufacturers 2011-2016

Table United States and Major Manufacturers Revenue of Anti-Obesity Drugs 2011-2016 (M USD)

Table United States Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drugs 2011-2016

Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of Pfizer

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Pfizer 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Pfizer 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of Pfizer 2011-2016

Table Pfizer Anti-Obesity Drugs SWOT Analysis

Table Merck Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of Merck

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merck 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Merck 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of Merck 2011-2016

Table Merck Anti-Obesity Drugs SWOT Analysis

Table F. Hoffmann-La Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of F. Hoffmann-La Roche

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of F. Hoffmann-La Roche 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of F. Hoffmann-La Roche 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of F. Hoffmann-La Roche 2011-2016

Table F. Hoffmann-La Roche Anti-Obesity Drugs SWOT Analysis

Table GlaxoSmithKline Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of GlaxoSmithKline

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GlaxoSmithKline 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of GlaxoSmithKline 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of GlaxoSmithKline 2011-2016

Table GlaxoSmithKline Anti-Obesity Drugs SWOT Analysis

Table AstraZeneca Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of AstraZeneca

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of AstraZeneca 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of AstraZeneca 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of AstraZeneca 2011-2016

Table AstraZeneca Anti-Obesity Drugs SWOT Analysis

Table Boehringer Ingelheim Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of Boehringer Ingelheim

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Boehringer Ingelheim 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of Boehringer Ingelheim 2011-2016

Table Boehringer Ingelheim Anti-Obesity Drugs SWOT Analysis

Table Novo Nordisk Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of Novo Nordisk

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Novo Nordisk 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Novo Nordisk 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of Novo Nordisk 2011-2016

Table Novo Nordisk Anti-Obesity Drugs SWOT Analysis

Table Eisai Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of Eisai

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eisai 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Eisai 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of Eisai 2011-2016

Table Eisai Anti-Obesity Drugs SWOT Analysis

Table Norgine Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of Norgine

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Norgine 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Norgine 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of Norgine 2011-2016

Table Norgine Anti-Obesity Drugs SWOT Analysis

Table Arena Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of Arena Pharmaceuticals

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Arena Pharmaceuticals 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Arena Pharmaceuticals 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of Arena Pharmaceuticals 2011-2016

Table Arena Pharmaceuticals Anti-Obesity Drugs SWOT Analysis

Table Orexigen Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of Orexigen Therapeutics

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Orexigen Therapeutics 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Orexigen Therapeutics 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of Orexigen Therapeutics 2011-2016

Table Orexigen Therapeutics Anti-Obesity Drugs SWOT Analysis

Table Vivus Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of Vivus

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Vivus 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Vivus 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of Vivus 2011-2016

Table Vivus Anti-Obesity Drugs SWOT Analysis

Table Alizyme Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of Alizyme

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Alizyme 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Alizyme 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of Alizyme 2011-2016

Table Alizyme Anti-Obesity Drugs SWOT Analysis

Table Rhythm Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of Rhythm Pharmaceuticals

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Rhythm Pharmaceuticals 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Rhythm Pharmaceuticals 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of Rhythm Pharmaceuticals 2011-2016

Table Rhythm Pharmaceuticals Anti-Obesity Drugs SWOT Analysis

Table Shionogi Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of Shionogi

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Shionogi 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Shionogi 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of Shionogi 2011-2016

Table Shionogi Anti-Obesity Drugs SWOT Analysis

Table Zafgan Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Anti-Obesity Drugs Picture and Specifications of Zafgan

Table Anti-Obesity Drugs Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Zafgan 2011-2016

Figure Anti-Obesity Drugs Capacity (K Doses), Production (K Doses) and Growth Rate of Zafgan 2011-2016

Figure Anti-Obesity Drugs Production (K Doses) and United States Market Share of Zafgan 2011-2016

Table Zafgan Anti-Obesity Drugs SWOT Analysis

Table Anti-Obesity Drugs Price by Regions 2011-2016

Table Anti-Obesity Drugs Price by Product Types 2011-2016

Table Anti-Obesity Drugs Price by Companies 2011-2016

Table Anti-Obesity Drugs Gross Margin by Companies 2011-2016

Table Price Comparison of Anti-Obesity Drugs by Regions 2011-2016 (USD/Dose)

Table Price of Different Anti-Obesity Drugs Product Types (USD/Dose)

Table Market Share of Different Anti-Obesity Drugs Price Level

Table Gross Margin of Different Anti-Obesity Drugs Applications

Table Marketing Channels Status of Anti-Obesity Drugs

Table Traders or Distributors of Anti-Obesity Drugs with Contact Information

Table Ex-work Price, Channel Price and End Buyer Price of Anti-Obesity Drugs (USD/Dose) in 2015

Table United States Import, Export, and Trade of Anti-Obesity Drugs (K Doses)

Figure United States Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drugs 2016-2021

Figure United States Capacity Utilization Rate of Anti-Obesity Drugs 2016-2021

Table United States Anti-Obesity Drugs Production by Type 2016-2021 (K Doses)

Table United States Anti-Obesity Drugs Production Market Share by Type 2016-2021

Figure United States Production Market Share of Anti-Obesity Drugs by Type in 2021

Figure United States Sales (K Doses) and Growth Rate of Anti-Obesity Drugs 2016-2021

Figure United States Sales Revenue (Million USD) and Growth Rate of Anti-Obesity Drugs 2016-2021

Figure United States Sales of Anti-Obesity Drugs by Applications 2016-2021 (K Doses)

Table United States Production Market Share of Anti-Obesity Drugs by Applications 2016-2021

Figure United States Production Market Share of Anti-Obesity Drugs by Applications in 2021

Table United States Production, Import, Export and Consumption of Anti-Obesity Drugs 2016-2021 (K Doses)

Table United States Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drugs 2016-2021

Table Major Raw Materials Suppliers of Anti-Obesity Drugs with Contact Information

Table Manufacturing Equipment Suppliers of Anti-Obesity Drugs with Contact Information

Table Major Players of Anti-Obesity Drugs with Contact Information

Table Key Consumers of Anti-Obesity Drugs with Contact Information

Table Supply Chain Relationship Analysis of Anti-Obesity Drugs

Table New Project SWOT Analysis of Anti-Obesity Drugs

Table New Project Investment Feasibility Analysis of Anti-Obesity Drugs

Table Part of Interviewees Record List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370